Gensun Biopharma Patents – Insights & Stats (Updated 2023)

Gensun Biopharma has a total of 56 patents globally, out of which 11 have been granted. Of these 56 patents, more than 75% patents are active. The United States of America is where Gensun Biopharma has filed the maximum number of patents, followed by China and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Gensun Biopharma.

Gensun Biopharma was founded in 2016. Gensun Biopharma is a biotechnology firm. Gensun Biopharma offers biological therapies for the management of cancer. Gensun’s pipeline includes compounds in the pre-IND and early stages of development.

Do read about some of the most popular patents of Gensun Biopharma which have been covered by us in this article and also you can find Gensun Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Gensun Biopharma patent portfolio.

How many patents does Gensun Biopharma have?

Gensun Biopharma has a total of 56 patents globally. These patents belong to 6 unique patent families. Out of 56 patents, 42 patents are active.

How Many Patents did Gensun Biopharma File Every Year?

Gensun Biopharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGensun Biopharma Applications FiledGensun Biopharma Patents Granted
202311
202233
2021123
202074
201924
20181
20178

How many Gensun Biopharma patents are Alive/Dead?

Worldwide Patents

Gensun Biopharma Worldwide Patent Filing

How Many Patents did Gensun Biopharma File in Different Countries?

Gensun Biopharma Worldwide Patent Filing

Countries in which Gensun Biopharma Filed Patents

CountryPatent
United States of America18
China9
Europe8
Japan5
Australia2
Brazil1
Taiwan1
Canada1
Hong Kong (S.A.R.)1
India1

Where are Research Centers of Gensun Biopharma Patents Located?

The Research Center for Gensun Biopharma is the United States of America.

10 Best Gensun Biopharma Patents

WO2020006509A1 is the most popular patent in the Gensun Biopharma portfolio. It has received 20 citations so far from companies like Merck Patent Gmbh, Epimab Biotherapeutics and Xencor.

Below is the list of 10 most cited patents of Gensun Biopharma:

Publication NumberCitation Count
WO2020006509A120
WO2018128939A115
WO2017165681A18
US10537637B24
CN112739717A3
CN112638401A3
CN109988237A3
WO2021155380A13
WO2020006511A13
US10851157B22

What Percentage of Gensun Biopharma US Patent Applications Were Granted?

Gensun Biopharma (Excluding its subsidiaries) has filed 13 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 100%.

Below are the key stats of Gensun Biopharma patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Gensun Biopharma?

Law FirmTotal ApplicationsSuccess Rate
Ping Wang13100.0%

What are Gensun Biopharma key innovation segments?

What Technologies are Covered by Gensun Biopharma?

The chart below distributes patents filed by Gensun Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Gensun Biopharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Gensun Biopharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Gensun Biopharma?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.